Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BJS Biotechnologies was a UK diagnostics and instrumentation company focused on ultrafast thermal cycling technology for polymerase chain reaction testing. The company developed the xxpress qPCR thermal cycler and related consumables, and later operated under the name Fast MDx to commercialize a low-cost, high-throughput molecular diagnostic testing platform. Its offerings were aimed at research and molecular diagnostics applications, including rapid sample-to-result workflows rather than therapeutic drug development. The legal entity BJS Biotechnologies Limited was dissolved in March 2025, although the Fast MDx brand and website have continued to present an active diagnostics offering at the same Greenford address. The business appears to sit at the intersection of life science tools, in vitro diagnostics, and laboratory automation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BJS.